Dividend compounder review

AREC

Arecor Therapeutics plc · LSE · GB

Healthcare · Biotechnology

Chart Factor Intelligence Back to Screener
Score34.50/100
Confidence82.00/100
DecisionInsufficient Data
RatingAvoid
Scoring

Quality breakdown

Dividend Reliability 0.0 / 25 Payment history, cuts, growth, and regularity.
Dividend Sustainability 8.5 / 20 Payout, free cash flow, dividend cover, and debt.
Business Quality 20.0 / 25 Scale, cash generation, growth, margins, and returns.
Valuation Discipline 6.0 / 15 Yield, P/E, and price stretch versus long-term trend.
Long-Term Trend 0.0 / 15 Trend line, long return history, and drawdown control.
Metrics

Dividend and business context

Dividend Years0
Dividend Yield0.00%
Payout Ratio0.0%
Dividend Cut 5YNo
Net Income£664,000
Free Cash Flow£-2.5M
FCF Covers DividendUnknown
Debt / Equity1.52
P/E31.2
Revenue Growth 5Y-10.7%
Net Margin38.7%
ROE15.8%
Price vs Trend-13.9%
3Y Return-73.4%
5Y Return-73.7%
CurrencyGBP
Warnings

Review flags

No usable dividend history found.
Free cash flow is negative.
Dividend diary

Activity record

AREC dividend review warning Warning · Warning

Free cash flow is negative.